Content Type: Research Publications

Isotretinoin Risk Evaluation and Mitigation Strategy and Pregnancy Incidence

March 6, 2026

Changes in Medicare Part D Plan Designs After the Inflation Reduction Act

March 6, 2026

Assessing Outcomes Emerging After Conversion to Regular Approval for Cancer Drug Indications Granted Accelerated Approval, 1992-2021

March 6, 2026

Regulatory and Clinical Outcomes of Nononcology Accelerated Approvals

March 6, 2026

Trends in Medicare Spending on Drugs for Pulmonary Arterial Hypertension, 2012-2022

March 6, 2026

Patient Perceptions of and Experiences with Risk Evaluation and Mitigation Strategies

March 6, 2026

Pharmaceutical Access in Brazil: Challenges and Opportunities

March 6, 2026

Pediatric Exclusivity-Associated Revenues and Labeling Changes, 2013-2023

March 6, 2026

Revenue Differences Between Top-Selling Small-Molecule Drugs and Biologics in Medicare

March 6, 2026

National Analysis of the Requirements and Implementation of State Prescription Drug Price Transparency Laws

March 6, 2026

Physician Perspectives on Pharmaceutical Promotion

March 6, 2026

Medicare Part D Savings Under the Manufacturer Discount Program vs Coverage Gap Discounts

March 6, 2026